Aldebaran Capital, LLC
CARMEL, IN · CIK 1448430 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$133.1m
reported value
+1.7% vs Q1 2026
39positions
60.0%in top 10
0 new
4 added
25 reduced
4 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BERKSHIRE HATHAWAY INC DEL BRK.B | $20.8m15.61% | Added +1.3k |
| ELI LILLY & CO LLY | $10.8m8.12% | Unchanged |
| MICROSOFT CORP MSFT | $7.5m5.62% | Reduced -310 |
| BUNGE GLOBAL SA BG | $7.1m5.34% | Reduced -978 |
| ISHARES TR IWS | $6.5m4.90% | Reduced -485 |
| OCCIDENTAL PETE CORP OXY | $6.5m4.86% | Reduced -20.8k |
| BANK AMERICA CORP BAC | $5.8m4.36% | Reduced -2.4k |
| SUNCOR ENERGY INC NEW SU | $5.5m4.12% | Reduced -1.2k |
| ACLARIS THERAPEUTICS INC ACRS | $5.0m3.72% | Reduced -10.4k |
| GLENCORE PLC GLNCY | $4.5m3.38% | Reduced -4.2k |
| CHEVRON CORP NEW CVX | $4.3m3.25% | Reduced -348 |
| LKQ CORP LKQ | $4.2m3.12% | Added +55.8k |
| CATO CORP NEW CATO | $3.8m2.85% | Reduced -6.7k |
| JPMORGAN CHASE & CO JPM | $3.7m2.77% | Unchanged |
| AMYLYX PHARMACEUTICALS INC AMLX | $3.5m2.64% | Reduced -2.0k |
| SIRIUSXM HOLDINGS INC SIRI | $3.4m2.53% | Reduced -1.2k |
| ABRDN ETFS BCI | $3.2m2.38% | Reduced -1.8k |
| FREEPORT-MCMORAN INC FCX | $3.0m2.28% | Reduced -554 |
| ISHARES TR EWJV | $2.9m2.18% | Added +49.3k |
| MOLINA HEALTHCARE INC MOH | $2.9m2.15% | Reduced -117 |
| CENTURY ALUM CO CENX | $2.4m1.80% | Reduced -5.6k |
| ZIFF DAVIS INC ZD | $2.2m1.62% | Added +1 |
| ENBRIDGE INC ENB | $2.1m1.61% | Reduced -454 |
| RICHARDSON ELECTRS LTD RELL | $1.8m1.34% | Unchanged |
| AN2 THEREAPEUTICS INC COM | $1.8m1.34% | Reduced -4.3k |
| BERKSHIRE HATHAWAY INC DEL BRK.A | $1.5m1.13% | Unchanged |
| TECTONIC THERAPEUTIC INC TECX | $1.3m0.95% | Reduced -387 |
| PATRICK INDS INC PATK | $1.2m0.92% | Reduced -262 |
| PMV PHARMACEUTICALS INC PMVP | $626.4k0.47% | Reduced -5.9k |
| MERCHANTS BANCORP IND MBIN | $506.2k0.38% | Unchanged |
| GENERAL ELECTRIC CO COM | $467.5k0.35% | Unchanged |
| Duke Energy Corp New COM | $455.7k0.34% | Unchanged |
| ATEA PHARMACEUTICALS INC AVIR | $410.0k0.31% | Reduced -1.8k |
| GE VERNOVA INC GEV | $390.1k0.29% | Unchanged |
| FORD MTR CO F | $382.2k0.29% | Unchanged |
| HURCO CO HURC | $313.6k0.24% | Reduced -30 |
| BANK MONTREAL QUE BMO | $300.4k0.23% | Unchanged |
| ONKURE THERAPEUTICS INC OKUR | $181.8k0.14% | Reduced -550 |
| IMAGENEBIO INC IMA | $106.9k0.08% | Reduced -442 |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| VERIZON COMMUNICATIONS INC VZ | $3.0m59.9k shares |
| KEZAR LIFE SCIENCES INC KZR | $596.1k80.3k shares |
| OCCIDENTAL PETE CORP OXY.WS | $306.2k7.1k shares |
| EXXON MOBIL CORP XOM | $211.2k1.2k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| CATO CORP NEW CATO · 13G · filed 2024-11-08 | 6.0%≈ $3.6m |